CGEM Cullinan Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$15,51
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$5,71rendah 52m
$23,19tinggi 52m
Kapitalisasi Pasar (MRQ)
$998M
P/E
-4.8
EPS
$-3.69
lencana Anda
Rentang 52M
$6–$23
Peringkat Analis
STRONG BUY
Target Harga
$33
P/E
-4.8
ROE
-44.0%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
CGEM Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$15.51
Kapitalisasi Pasar (MRQ)
$998M
P/E
-4.8
EPS
$-3.69
ROE
-44.0%
Rentang 52M
$6–$23
CGEM Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan·2020-12-31 → 2022-12-31
EPS$-3.692021-12-31 → 2023-12-31
Arus Kas Bebas$-176M2022-12-31 → 2025-12-31
Margin bersih·2021-12-31 → 2021-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | CGEM | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -4.8rata-rata 5T ≈-3.1 | ≈-3.1 | · | · | |
| P/B (MRQ) | 3.1rata-rata 5T ≈1.2 | ≈1.2 | 4.2 | Nilai wajar | |
| Price / FCF (Harga / FCF) | -5.3rata-rata 5T ≈-3.9 | ≈-3.9 | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -5.3rata-rata 5T ≈-6.3 | ≈-6.3 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 2.3rata-rata 5T ≈1.2 | ≈1.2 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | CGEM | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -41.1%rata-rata 5T ≈-19.7% | ≈-19.7% | -21.8% | Lemah | |
| ROE | -44.0%rata-rata 5T ≈-21.0% | ≈-21.0% | -40.2% | Lemah | |
| ROIC | -59.1%rata-rata 5T ≈-27.9% | ≈-27.9% | -34.2% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | CGEM | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 8.4rata-rata 5T ≈17.4 | ≈17.4 | 8.4 | Sejajar | |
| Quick Ratio (Rasio Cepat) | 10.0rata-rata 5T ≈17.0 | ≈17.0 | 1.5 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
4.3%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 6, 2026 | $-0.81 | $-0.83 | 1.9% |
| 31 Maret 2026 | Mei 7, 2026 | $-0.75 | $-0.85 | 11.3% |
| 31 Des. 2025 | $-0.77 | $-0.83 | 6.7% | |
| 30 Sep. 2025 | $-0.77 | $-0.98 | 21.1% | |
| 30 Juni 2025 | $-1.07 | $-0.85 | -25.9% | |
| 31 Maret 2025 | $-0.74 | $-0.82 | 9.5% | |
| 31 Des. 2024 | $-0.73 | $-0.77 | 5.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $19M | $0 | |
| R&D Expense | $187M | $143M | $148M | $92M | $58M | $43M | |
| SG&A Expense | $54M | $54M | $42M | $40M | $29M | $17M | |
| Operating Expenses | $242M | $197M | $191M | $132M | $87M | $60M | |
| Operating Income | $-242M | $-197M | $-191M | $145M | $-68M | $-60M | |
| Interest Income | $22M | $30M | $22M | $7M | $477.0K | $888.0K | |
| Other Non-op | $-443.0K | $-199.0K | $239.0K | $57.0K | $-8.0K | $-11.0K | |
| Pretax Income | $-220M | $-167M | $-169M | $151M | $-67M | · | |
| Income Tax | $0 | $117.0K | $-14M | $42M | $0 | · | |
| Net Income | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| EPS (Basic) | · | · | $-3.69 | $2.46 | $-1.52 | · | |
| EPS (Diluted) | · | · | $-3.69 | $2.38 | $-1.52 | · | |
| Shares (Basic) | · | · | 41,550,000 | 45,164,000 | 43,077,000 | · | |
| Shares (Diluted) | · | · | 41,550,000 | 46,640,000 | 43,077,000 | · | |
| EBITDA | $-241M | $-197M | $-191M | $145M | $-68M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $83M | $98M | $156M | $60M | $168M | |
| Short-term Investments | $290M | $316M | $369M | $311M | $231M | $42M | |
| Prepaid Expense | $9M | $16M | $13M | $7M | $6M | $2M | |
| Other Current Assets | · | · | $4M | · | · | · | |
| Current Assets | $387M | $415M | $480M | $474M | $297M | $212M | |
| PP&E (Net) | $421.0K | $683.0K | $989.0K | $1M | $77.0K | $130.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $309.0K | $309.0K | |
| Accum. Depreciation | $969.0K | $658.0K | $352.0K | $135.0K | $232.0K | $179.0K | |
| Other Non-current Assets | $297.0K | $366.0K | $459.0K | $459.0K | $147.0K | $2M | |
| Total Assets | $448M | $622M | $484M | $561M | $437M | $215M | |
| Accounts Payable | $841.0K | $2M | $2M | $3M | $3M | $10M | |
| Accrued Liabilities | $36M | $28M | $24M | $14M | $9M | $5M | |
| Current Liabilities | $38M | $31M | $28M | $22M | $12M | $14M | |
| Capital Leases | $2M | $849.0K | $2M | $4M | · | · | |
| Total Liabilities | $40M | $31M | $30M | $26M | $12M | $14M | |
| Common Stock | $6.0K | $6.0K | $4.0K | $5.0K | $4.0K | $3.0K | |
| Retained Earnings | $-588M | $-368M | $-201M | $-48M | $-159M | $-93M | |
| AOCI | $1M | $-133.0K | $-129.0K | $-3M | $-838.0K | $-2.0K | |
| Stockholders' Equity | $409M | $590M | $454M | $535M | $425M | $199M | |
| Liabilities + Equity | $448M | $622M | $484M | $561M | $437M | $215M | |
| Shares Outstanding | 60,244,136 | 58,510,610 | 42,900,083 | 45,796,449 | 44,292,102 | 29,831,125 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $311.0K | $306.0K | $310.0K | $93.0K | $53.0K | $62.0K | |
| Stock-based Comp | $36M | $38M | $30M | $28M | $24M | $15M | |
| Deferred Tax | · | $3M | $5M | · | $0 | $0 | |
| Other Non-cash | $8M | $-19M | $-17M | $-266M | $-2M | · | |
| Operating Cash Flow | $-176M | $-145M | $-134M | $-127M | $-43M | $-30M | |
| CapEx | $49.0K | $0 | $208.0K | $1M | $0 | $10.0K | |
| Investing Cash Flow | $180M | $-136M | $36M | $249M | $-334M | $-5M | |
| Stock Issued | $0 | $263M | $38M | $0 | $3M | $145M | |
| Stock Repurchased | · | · | · | · | · | $7M | |
| Net Stock Activity | $0 | $263M | $38M | $6M | · | · | |
| Financing Cash Flow | $1M | $266M | $41M | $-26M | $269M | $140M | |
| Taxes Paid | $-3M | $-2M | $-4M | $38M | $0 | · | |
| Free Cash Flow | $-176M | $-145M | $-134M | $-128M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -358.7% | · | |
| Net Margin | · | · | · | · | -346.1% | · | |
| EBITDA Margin | · | · | · | · | -358.4% | · | |
| ROA | -41.1% | -30.3% | -29.3% | 22.3% | -20.1% | · | |
| ROE | -44.0% | -32.1% | -31.0% | 23.2% | -21.0% | · | |
| ROIC | -59.1% | -33.4% | -38.6% | 19.5% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 | · | |
| Quick Ratio | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.78 | $10.09 | $10.58 | $11.68 | $9.59 | · | |
| Revenue / Share | · | · | · | $0.00 | · | · | |
| Cash Flow / Share | · | · | $-3.23 | $-2.72 | · | · | |
| Cash / Share | $1.47 | $1.42 | $2.29 | $3.41 | $1.35 | · | |
| EPS (TTM) | $-3.21 | $-3.21 | $-3.69 | $2.38 | $-1.52 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $19M | $0 | |
| Net Income TTM | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| Market Cap | $624M | $713M | $437M | $483M | $683M | · | |
| P/E | -3.2 | -3.8 | -2.8 | 4.4 | -10.2 | · | |
| P/S | · | · | · | · | 36.1 | · | |
| P/B | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Tangible Book | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Cash Flow | -3.5 | -4.9 | -3.3 | -3.8 | -15.7 | · | |
| P / FCF | -3.5 | -4.9 | -3.3 | -3.8 | · | · | |
| Earnings Yield | -31.0% | -26.4% | -36.2% | 22.6% | -9.8% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| R&D Expense | $44M | $42M | $43M | $42M | $61M | $41M | $40M | $36M | $36M | $31M | $35M | $34M | $27M | $52M | $21M | $20M | |
| SG&A Expense | $13M | $12M | $12M | $14M | $15M | $14M | $15M | $13M | $14M | $12M | $11M | $11M | $10M | $11M | $11M | $10M | |
| Operating Expenses | $57M | $54M | $55M | $56M | $76M | $55M | $55M | $49M | $50M | $43M | $45M | $45M | $38M | $63M | $33M | $30M | |
| Operating Income | $-57M | $-54M | $-55M | $-56M | $-76M | $-55M | $-55M | $-49M | $-50M | $-43M | $-45M | $-45M | $-38M | $-63M | $-33M | $-30M | |
| Interest Income | $4M | $4M | $5M | $5M | $6M | $7M | $8M | $8M | $8M | $6M | $6M | $6M | $5M | $5M | $3M | $2M | |
| Other Non-op | $-98.0K | $-62.0K | $-69.0K | $-108.0K | $-181.0K | $-85.0K | $6.0K | $-89.0K | $-72.0K | $-44.0K | $-117.0K | $180.0K | $69.0K | $107.0K | $298.0K | $0 | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-40M | $-39M | $-32M | $-58M | $-29M | $-27M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | $-14M | $0 | $0 | $0 | $-2M | $-3M | |
| Net Income | $-54M | $-50M | $-51M | $-51M | $-70M | $-49M | $-48M | $-41M | $-42M | $-37M | $-24M | $-39M | $-32M | $-58M | $-27M | $-25M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.63 | $-0.54 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.58 | $-0.54 | |
| Shares (Basic) | · | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | · | 45,611,000 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | · | 45,611,000 | |
| EBITDA | $-57M | $-54M | · | $-56M | $-76M | $-55M | · | $-49M | $-50M | $-43M | · | $-45M | $-38M | $-63M | · | $-30M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $75M | $88M | $103M | $73M | $77M | $83M | $102M | $115M | $74M | $98M | $65M | $142M | $122M | $156M | $243M | |
| Short-term Investments | $256M | $277M | $290M | $229M | $193M | $227M | $316M | $476M | $547M | $359M | $369M | $402M | $350M | $269M | $311M | $333M | |
| Prepaid Expense | $7M | $10M | $9M | $10M | $10M | $14M | $16M | $14M | $15M | $13M | $13M | $619.0K | $619.0K | $8M | · | $619.0K | |
| Current Assets | $342M | $361M | $387M | $342M | $276M | $318M | $415M | $592M | $678M | $446M | $480M | $477M | $498M | $399M | $474M | $582M | |
| PP&E (Net) | $263.0K | $342.0K | $421.0K | $489.0K | $569.0K | $607.0K | $683.0K | $760.0K | $836.0K | $913.0K | $989.0K | $1M | $1M | $1M | $1M | $792.0K | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $969.0K | · | · | · | $658.0K | · | · | · | $352.0K | · | · | · | $135.0K | · | |
| Other Non-current Assets | $297.0K | $297.0K | $297.0K | $361.0K | $367.0K | $366.0K | $366.0K | $460.0K | $460.0K | $460.0K | $459.0K | $459.0K | $459.0K | $459.0K | $459.0K | $460.0K | |
| Total Assets | $364M | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | |
| Accounts Payable | $4M | $3M | $841.0K | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $2M | $951.0K | $2M | $2M | $3M | $2M | |
| Accrued Liabilities | $36M | $32M | $36M | $30M | $24M | $23M | $28M | $21M | $21M | $17M | $24M | $21M | $16M | $18M | $14M | $14M | |
| Current Liabilities | $41M | $35M | $38M | $33M | $28M | $27M | $31M | $24M | $23M | $22M | $28M | $23M | $20M | $26M | $22M | $27M | |
| Capital Leases | $1M | $2M | $2M | $0 | $125.0K | $493.0K | $849.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | |
| Total Liabilities | $42M | $37M | $40M | $33M | $28M | $28M | $31M | $25M | $25M | $24M | $30M | $26M | $22M | $29M | $26M | $31M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | |
| Retained Earnings | $-691M | $-638M | $-588M | $-537M | $-487M | $-417M | $-368M | $-321M | $-280M | $-238M | $-201M | $-177M | $-138M | $-106M | $-48M | $-21M | |
| AOCI | $-134.0K | $127.0K | $1M | $973.0K | $607.0K | $505.0K | $-133.0K | $970.0K | $-476.0K | $-331.0K | $-129.0K | $-1M | $-2M | $-1M | $-3M | $-4M | |
| Stockholders' Equity | $322M | $366M | $409M | $451M | $492M | $552M | $590M | $628M | $656M | $426M | $454M | $469M | $500M | $486M | $535M | $586M | |
| Liabilities + Equity | $364M | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | |
| Shares Outstanding | 64,345,770 | 61,451,380 | 60,244,136 | 59,076,259 | 59,074,391 | 58,698,919 | 58,510,610 | 58,141,130 | 57,871,638 | 43,065,645 | 42,900,083 | 42,760,644 | 42,735,304 | 39,343,601 | 45,796,449 | 45,743,027 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $79.0K | $79.0K | $79.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $80.0K | $81.0K | $72.0K | $59.0K | $9.0K | |
| Stock-based Comp | $8M | $8M | $7M | $9M | $10M | $9M | $10M | $9M | $11M | $8M | $8M | $8M | $8M | $7M | $8M | $5M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $-4M | · | · | · | $-9M | · | · | · | $-366.0K | · | · | |
| Operating Cash Flow | $-38M | $-46M | $-38M | $-37M | $-58M | $-43M | $-37M | $-34M | $-36M | $-38M | $-18M | $-34M | $-31M | $-51M | $-25M | $-54M | |
| CapEx | · | · | $11.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $49.0K | $159.0K | $882.0K | $251.0K | |
| Investing Cash Flow | $41M | $32M | $22M | $67M | $53M | $37M | $16M | $20M | $-185M | $13M | $51M | $-43M | $12M | $15M | $-29M | $-58M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | $38M | $-36.0K | $0 | $-4M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36.0K | · | · | |
| Financing Cash Flow | $1M | $380.0K | $715.0K | $0 | $373.0K | $0 | $2M | $1M | $262M | $1M | $248.0K | $112.0K | $39M | $2M | $-33M | $1M | |
| Taxes Paid | · | · | $0 | $0 | $-3M | $0 | $0 | $0 | $2M | $-4M | $-9M | $0 | $5M | $75.0K | $5M | $33M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-38M | · | · | · | $-51M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.2% | -10.1% | · | -8.9% | -11.7% | -9.4% | · | -7.1% | -7.0% | -7.7% | · | -7.0% | -5.4% | -12.2% | · | -4.6% | |
| ROE | -13.2% | -10.8% | · | -9.4% | -12.2% | -9.9% | · | -7.4% | -7.3% | -8.2% | · | -7.4% | -5.8% | -12.8% | · | -4.8% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | -9.7% | -7.5% | -12.9% | · | -4.6% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 10.3 | · | 10.4 | 9.8 | 11.6 | · | 24.5 | 28.9 | 20.3 | · | 20.3 | 25.3 | 15.2 | · | 21.5 | |
| Quick Ratio | 8.2 | 10.0 | · | 10.2 | 9.5 | 11.1 | · | 23.9 | 28.2 | 19.7 | · | 19.9 | 25.0 | 14.9 | · | 21.2 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.00 | $5.96 | · | $7.64 | $8.33 | $9.40 | · | $10.80 | $11.34 | $9.88 | · | $10.96 | $11.69 | $12.34 | · | $12.81 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.89 | · | · | · | $-1.25 | · | · | |
| Cash / Share | $1.22 | $1.22 | · | $1.75 | $1.23 | $1.31 | · | $1.76 | $1.99 | $1.72 | · | $1.52 | $3.32 | $3.10 | · | $5.30 | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | $-3.73 | $-3.36 | $1.23 | · | $2.20 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-205M | $-221M | · | $-217M | $-207M | $-179M | · | $-144M | $-142M | $-132M | · | $-156M | $-142M | $65M | · | $105M | |
| Market Cap | $1.17B | $873M | · | $350M | $445M | $444M | · | $973M | $1.01B | $734M | · | $387M | $460M | $402M | · | $586M | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | -2.4 | -3.2 | 8.3 | · | 5.8 | |
| P/B | 3.6 | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | |
| P / Tangible Book | 3.6 | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | |
| P / Cash Flow | · | -19.0 | · | · | · | -10.3 | · | · | · | -19.2 | · | · | · | -7.9 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | -41.2% | -31.2% | 12.0% | · | 17.2% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | · | · | · | $0 | $19M |
| Margin Operasi % | · | · | · | · | -358.7% |
| Laba Bersih | $-220M | $-167M | $-153M | $111M | $-66M |
| EPS Dilusian | · | · | $-3.69 | $2.38 | $-1.52 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 |
| Rasio Cepat | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-176M | $-145M | $-134M | $-128M | · |
Pemilik institusional (13F) 196 pengaju · $1.3B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
196
Nilai yang dipegang
$1.3B
Posisi baru
32
Posisi yang keluar
19
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 32 (-8 vs Kuartal sebelumnya) | 19 (+4 vs Kuartal sebelumnya) | 82 (+22 vs Kuartal sebelumnya) | 47 (+3 vs Kuartal sebelumnya) | +6.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| MPM BIOIMPACT LLC | $177.207.720 | 9.731.341 | 13,90% | Saham |
| Lynx1 Capital Management LP | $163.225.335 | 8.963.500 | 12,81% | Saham |
| BVF INC/IL | $104.719.937 | 5.750.683 | 8,22% | Saham |
| BlackRock, Inc. | $95.288.670 | 5.232.766 | 7,48% | Saham |
| STATE STREET CORP | $66.805.698 | 3.668.627 | 5,24% | Saham |
| Kynam Capital Management, LP | $56.708.344 | 3.114.132 | 4,45% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $47.602.142 | 2.614.066 | 3,73% | Saham |
| RTW INVESTMENTS, LP | $43.054.759 | 2.364.347 | 3,38% | Saham |
| Siren, L.L.C. | $34.478.996 | 1.893.410 | 2,71% | Saham |
| VANGUARD GROUP INC | $34.139.516 | 3.298.504 | 2,68% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $28.182.326 | 1.547.309 | 2,21% | Saham |
| Blue Owl Capital Holdings LP | $28.039.102 | 1.539.764 | 2,20% | Saham |
| Venrock Adviser, LLC | $25.129.163 | 1.379.965 | 1,97% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $19.714.346 | 1.082.611 | 1,55% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $19.061.499 | 1.046.694 | 1,50% | Saham |
| GOLDMAN SACHS GROUP INC | $18.239.100 | 1.001.598 | 1,43% | Saham |
| Affinity Asset Advisors, LLC | $15.947.590 | 875.760 | 1,25% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.452.474 | 738.741 | 1,06% | Saham |
| BOONE CAPITAL MANAGEMENT LLC | $12.827.889 | 704.442 | 1,01% | Saham |
| Elmind Capital, LP | $12.564.900 | 690.000 | 0,99% | Saham |
| MORGAN STANLEY | $11.454.726 | 629.035 | 0,90% | Saham |
| TWIN FOCUS CAPITAL PARTNERS, LLC | $10.843.855 | 595.489 | 0,85% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $10.586.165 | 581.338 | 0,83% | Saham |
| NORTHERN TRUST CORP | $10.399.367 | 571.080 | 0,82% | Saham |
| BANK OF AMERICA CORP /DE/ | $9.293.018 | 510.325 | 0,73% | Saham |
| Nuveen, LLC | $8.594.154 | 471.947 | 0,67% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.450.059 | 464.034 | 0,66% | Saham |
| PERCEPTIVE ADVISORS LLC | $7.766.164 | 426.478 | 0,61% | Saham |
| TCG Crossover Management, LLC | $7.407.573 | 406.786 | 0,58% | Saham |
| CITADEL ADVISORS LLC | $7.238.184 | 397.484 | 0,57% | Saham |
| DEUTSCHE BANK AG\ | $6.971.516 | 382.840 | 0,55% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $6.612.707 | 363.136 | 0,52% | Saham |
| MILLENNIUM MANAGEMENT LLC | $6.304.885 | 346.232 | 0,49% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $5.951.228 | 326.811 | 0,47% | Saham |
| GREAT POINT PARTNERS LLC | $5.463.000 | 300.000 | 0,43% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $5.326.425 | 292.500 | 0,42% | Saham |
| JPMORGAN CHASE & CO | $5.206.063 | 282.631 | 0,41% | Saham |
| TWO SIGMA INVESTMENTS, LP | $4.963.700 | 272.581 | 0,39% | Saham |
| Bleichroeder LP | $4.552.500 | 250.000 | 0,36% | Saham |
| UBS Group AG | $4.527.498 | 248.627 | 0,36% | Saham |
| FMR LLC | $4.372.486 | 240.115 | 0,34% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.333.980 | 238.000 | 0,34% | Saham |
| Susquehanna Portfolio Strategies, LLC | $4.258.263 | 233.842 | 0,33% | Saham |
| PFM Health Sciences, LP | $3.504.369 | 192.442 | 0,27% | Saham |
| MOORE CAPITAL MANAGEMENT, LP | $3.458.917 | 189.946 | 0,27% | Saham |
| Bank of New York Mellon Corp | $3.114.469 | 171.031 | 0,24% | Saham |
| Squarepoint Ops LLC | $3.061.411 | 168.117 | 0,24% | Saham |
| PRUDENTIAL FINANCIAL INC | $3.051.177 | 167.555 | 0,24% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $2.999.478 | 164.716 | 0,24% | Saham |
| AMERICAN CENTURY COMPANIES INC | $2.846.533 | 156.317 | 0,22% | Saham |
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 19 Jan. 2021 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 23 orang dalam · 12 pejabat · 12 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Nadim Ahmed | President and CEO | 24 Feb. 2026 S | 390.803 | 0 | 3 | $-517.990 |
| Owen Hughes | President and CEO | 12 Jan. 2021 P | 506.226 | 0 | 0 | $0 |
| Mary Kay Fenton | Chief Financial Officer | 30 Juni 2026 A | 127.921 | 0 | 1 | $-59.901 |
| Jeffrey Trigilio | Chief Financial Officer | 22 Feb. 2024 A | 133.919 | 0 | 0 | $0 |
| Jennifer Michaelson | Chief Scientific Officer | 8 Sep. 2026 M | 158.844 | 0 | 18 | $-1.615.830 |
| Jacquelyn L Sumer | Chief Legal Officer | 30 Juni 2026 A | 130.559 | 0 | 3 | $-136.724 |
| Jeffrey Alan Jones | Chief Medical Officer | 24 Feb. 2026 S | 159.968 | 0 | 3 | $-178.948 |
| Corrine Savill | Chief Business Officer | 18 Feb. 2026 A | 240.990 | 0 | 0 | $0 |
| Patrick Baeuerle | Chief Scientific Officer | 17 Feb. 2023 A | 76.000 | 0 | 0 | $0 |
| Leigh Zawel | Chief Scientific Officer, Small Molecules | 11 Feb. 2022 A | 69.785 | 0 | 0 | $0 |
| Raymond T Keane | Chief Legal Officer | 11 Feb. 2022 A | 24.124 | 0 | 0 | $0 |
| Jon Marc Wigginton | Chief Medical Officer | 7 Jan. 2021 A | · | 0 | 0 | $0 |
| Mittie Doyle | Direktur | 16 Juni 2026 A | · | 0 | 0 | $0 |
| David D. Meek | Direktur | 16 Juni 2026 A | · | 0 | 0 | $0 |
| Anthony Rosenberg | Direktur | 16 Juni 2026 A | · | 0 | 0 | $0 |
| Stephen W Webster | Direktur | 16 Juni 2026 A | · | 0 | 0 | $0 |
| Andrew R Allen | Direktur | 16 Juni 2026 A | · | 0 | 0 | $0 |
| Mary Thistle | Direktur | 16 Juni 2026 A | · | 0 | 0 | $0 |
| David P. Ryan | Direktur | 12 Juni 2025 A | · | 0 | 0 | $0 |
| Anne-Marie Martin | Direktur | 12 Juni 2025 A | · | 0 | 0 | $0 |
| Thomas Ebeling | Direktur | 10 Juni 2024 M | 186.653 | 0 | 0 | $0 |
| ANSBERT GADICKE | Direktur | 22 Juni 2022 A | 7.648.268 | 0 | 0 | $0 |
| Morana Jovan-Embiricos | Pemilik 10% | 24 Juni 2022 M | 207.803 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 33 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,81% | 22.687 NS | 31 Juli 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 0,69% | 136.657 SH | 2 Okt. 2026 | Harian |
| IWC · iShares Trust | 0,30% | 205.569 SH | 11 Sep. 2026 | Harian |
| LABU · Direxion Shares ETF Trust | 0,27% | 80.791 NS | 31 Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 114.553 SH | 19 Agu 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 14.989 SH | 2 Okt. 2026 | Harian |
| PWS · Pacer Funds Trust | 0,08% | 1.104 NS | 31 Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 345.074 SH | 11 Sep. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,07% | 53.076 SH | 19 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 4.556 SH | 2 Okt. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 98.778 SH | 2 Okt. 2026 | Harian |
| IWM · iShares Trust | 0,04% | 1.560.323 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,03% | 28.892 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 348.112 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,02% | 188.192 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 621.038 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 113.923 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17.979 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 2.558 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.236 SH | 10 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,01% | 170.697 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6.292 NS | 31 Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 3.792 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 16.447 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17.021 SH | 4 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 72.679 SH | 11 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 17.018 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.929.766 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.664 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 567.459 SH | 11 Sep. 2026 | Harian |
| ISCB · iShares Trust | · | 2.054 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 10.177 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 117.043 SH | 11 Sep. 2026 | Harian |
CGEM Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 19 analis
BELI
Target median
$35.00
+125,7%
9 47,4%
Beli Kuat
9 47,4%
Beli
1 5,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
11 analis · 2026-10-02Target rata-rata $33.45 +115,7%
← Di bawah semua target
Harga saat ini $15.51
Rendah$23.00
Rata-rata$33.45
Tinggi$42.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
| AKTS | · | · | · | · | · | · |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| ODTX | · | · | · | · | · | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026